Automatic detection of pathological myopia using variational level set

Efficacy of a Deep Learning System for Screening Myopic Maculopathy Based on Color Fundus Photographs

INTRODUCTION

The maculopathy in highly myopic eyes is complex. Its clinical diagnosis is a huge workload and subjective. To simply and quickly classify pathologic myopia (PM), a deep learning algorithm was developed and assessed to screen myopic maculopathy lesions based on color fundus photographs.

METHODS

This study included 10,347 ocular fundus photographs from 7606 participants. Of these photographs, 8210 were used for training and validation, and 2137 for external testing. A deep learning algorithm was trained, validated, and externally tested to screen myopic maculopathy which was classified into four categories: normal or mild tessellated fundus, severe tessellated fundus, early-stage PM, and advanced-stage PM. The area under the precision-recall curve, the area under the receiver operating characteristic curve (AUC), sensitivity, specificity, accuracy, and Cohen's kappa were calculated and compared with those of retina specialists.

RESULTS

In the validation data set, the model detected normal or mild tessellated fundus, severe tessellated fundus, early-stage PM, and advanced-stage PM with AUCs of 0.98, 0.95, 0.99, and 1.00, respectively; while in the external-testing data set of 2137 photographs, the model had AUCs of 0.99, 0.96, 0.98, and 1.00, respectively.

CONCLUSIONS

We developed a deep learning model for detection and classification of myopic maculopathy based on fundus photographs. Our model achieved high sensitivities, specificities, and reliable Cohen's kappa, compared with those of attending ophthalmologists.

Applications of Artificial Intelligence in Myopia: Current and Future Directions

With the continuous development of computer technology, big data acquisition and imaging methods, the application of artificial intelligence (AI) in medical fields is expanding. The use of machine learning and deep learning in the diagnosis and treatment of ophthalmic diseases is becoming more widespread. As one of the main causes of visual impairment, myopia has a high global prevalence. Early screening or diagnosis of myopia, combined with other effective therapeutic interventions, is very important to maintain a patient's visual function and quality of life. Through the training of fundus photography, optical coherence tomography, and slit lamp images and through platforms provided by telemedicine, AI shows great application potential in the detection, diagnosis, progression prediction and treatment of myopia. In addition, AI models and wearable devices based on other forms of data also perform well in the behavioral intervention of myopia patients. Admittedly, there are still some challenges in the practical application of AI in myopia, such as the standardization of datasets; acceptance attitudes of users; and ethical, legal and regulatory issues. This paper reviews the clinical application status, potential challenges and future directions of AI in myopia and proposes that the establishment of an AI-integrated telemedicine platform will be a new direction for myopia management in the post-COVID-19 period.

Peripapillary Atrophy Segmentation and Classification Methodologies for Glaucoma Image Detection: A Review

Information-based image processing and computer vision methods are utilized in several healthcare organizations to diagnose diseases. The irregularities in the visual system are identified over fundus images shaped over a fundus camera. Among ophthalmology diseases, glaucoma is measured as the most common case that can lead to neurodegenerative illness. The unsuitable fluid pressure inside the eye within the visual system is described as the major cause of those diseases. Glaucoma has no symptoms in the early stages, and if it is not treated, it may result in total blindness. Diagnosing glaucoma at an early stage may prevent permanent blindness. Manual inspection of the human eye may be a solution, but it depends on the skills of the individuals involved. The auto diagnosis of glaucoma by applying a consolidation of computer vision, artificial intelligence, and image processing can aid in the ban and detection of those diseases. In this review article, we aim to introduce a review of the numerous approaches based on peripapillary atrophy segmentation and classification that can detect these diseases, as well as details about the publicly available image benchmarks, datasets, and measurement of performance. The review article introduces the demonstrated research of numerous available study models that objectively diagnose glaucoma via peripapillary atrophy from the lowest level of feature extraction to the current direction based on deep learning. The advantages and disadvantages of each method are addressed in detail, and tabular descriptions are included to highlight the results of each category. Moreover, the frameworks of each approach and fundus image datasets are provided. The improved reporting of our study would help in providing possible future work directions to diagnose glaucoma in conclusion.

AI-Model for Identifying Pathologic Myopia Based on Deep Learning Algorithms of Myopic Maculopathy Classification and "Plus" Lesion Detection in Fundus Images

Background: Pathologic myopia (PM) associated with myopic maculopathy (MM) and “Plus” lesions is a major cause of irreversible visual impairment worldwide. Therefore, we aimed to develop a series of deep learning algorithms and artificial intelligence (AI)–models for automatic PM identification, MM classification, and “Plus” lesion detection based on retinal fundus images.

Materials and Methods: Consecutive 37,659 retinal fundus images from 32,419 patients were collected. After excluding 5,649 ungradable images, a total dataset of 32,010 color retinal fundus images was manually graded for training and cross-validation according to the META-PM classification. We also retrospectively recruited 1,000 images from 732 patients from the three other hospitals in Zhejiang Province, serving as the external validation dataset. The area under the receiver operating characteristic curve (AUC), sensitivity, specificity, accuracy, and quadratic-weighted kappa score were calculated to evaluate the classification algorithms. The precision, recall, and F1-score were calculated to evaluate the object detection algorithms. The performance of all the algorithms was compared with the experts’ performance. To better understand the algorithms and clarify the direction of optimization, misclassification and visualization heatmap analyses were performed.

Results: In five-fold cross-validation, algorithm I achieved robust performance, with accuracy = 97.36% (95% CI: 0.9697, 0.9775), AUC = 0.995 (95% CI: 0.9933, 0.9967), sensitivity = 93.92% (95% CI: 0.9333, 0.9451), and specificity = 98.19% (95% CI: 0.9787, 0.9852). The macro-AUC, accuracy, and quadratic-weighted kappa were 0.979, 96.74% (95% CI: 0.963, 0.9718), and 0.988 (95% CI: 0.986, 0.990) for algorithm II. Algorithm III achieved an accuracy of 0.9703 to 0.9941 for classifying the “Plus” lesions and an F1-score of 0.6855 to 0.8890 for detecting and localizing lesions. The performance metrics in external validation dataset were comparable to those of the experts and were slightly inferior to those of cross-validation.

Conclusion: Our algorithms and AI-models were confirmed to achieve robust performance in real-world conditions. The application of our algorithms and AI-models has promise for facilitating clinical diagnosis and healthcare screening for PM on a large scale.

Development of deep learning-based detecting systems for pathologic myopia using retinal fundus images

Globally, cases of myopia have reached epidemic levels. High myopia and pathological myopia (PM) are the leading cause of visual impairment and blindness in China, demanding a large volume of myopia screening tasks to control the rapid growing myopic prevalence. It is desirable to develop the automatically intelligent system to facilitate these time- and labor- consuming tasks. In this study, we designed a series of deep learning systems to detect PM and myopic macular lesions according to a recent international photographic classification system (META-PM) classification based on color fundus images. Notably, our systems recorded robust performance both in the test and external validation dataset. The performance was comparable to the general ophthalmologist and retinal specialist. With the extensive adoption of this technology, effective mass screening for myopic population will become feasible on a national scale.

Lu et al. develop a deep-learning based detection system for identifying pathological myopia and myopic macular legions in retinal fundus images. The system performance is comparable to human experts, but much faster, easing the burden of human time on screening for myopia.

A survey on computer aided diagnosis for ocular diseases

Background

Computer Aided Diagnosis (CAD), which can automate the detection process for ocular diseases, has attracted extensive attention from clinicians and researchers alike. It not only alleviates the burden on the clinicians by providing objective opinion with valuable insights, but also offers early detection and easy access for patients.

Method

We review ocular CAD methodologies for various data types. For each data type, we investigate the databases and the algorithms to detect different ocular diseases. Their advantages and shortcomings are analyzed and discussed.

Result

We have studied three types of data (i.e., clinical, genetic and imaging) that have been commonly used in existing methods for CAD. The recent developments in methods used in CAD of ocular diseases (such as Diabetic Retinopathy, Glaucoma, Age-related Macular Degeneration and Pathological Myopia) are investigated and summarized comprehensively.

Conclusion

While CAD for ocular diseases has shown considerable progress over the past years, the clinical importance of fully automatic CAD systems which are able to embed clinical knowledge and integrate heterogeneous data sources still show great potential for future breakthrough.

Peripapillary atrophy detection by sparse biologically inspired feature manifold

Peripapillary atrophy (PPA) is an atrophy of pre-existing retina tissue. Because of its association with eye diseases such as myopia and glaucoma, PPA is an important indicator for diagnosis of these diseases. Experienced ophthalmologists are able to determine the presence of PPA using visual information from the retinal images. However, it is tedious, time consuming and subjective to examine all images especially in a screening program. This paper presents biologically inspired feature (BIF) for the automatic detection of PPA. BIF mimics the process of cortex for visual perception. In the proposed method, a focal region is segmented from the retinal image and the BIF is extracted. As BIF is an intrinsically low dimensional feature embedded in a high dimensional space, it is not suitable to measure the similarity between two BIFs directly based on the Euclidean distance. Therefore, it is necessary to obtain a suitable mapping to reduce the dimensionality. In this paper, we explore sparse transfer learning to transfer the label information from ophthalmologists to the sample distribution knowledge contained in all samples. Selective pair-wise discriminant analysis is used to define two strategies of sparse transfer learning: negative and positive sparse transfer learning. Experimental results show that negative sparse transfer learning is superior to the positive one for this task. The proposed BIF based approach achieves an accuracy of more than 90% in detecting PPA, much better than previous methods. It can be used to save the workload of ophthalmologists and thus reduce the diagnosis costs.